Methods for determining cd8+ t-cell epitopes
CA 2536735 C · Owner: Harding, Fiona A. · Inventors: Mucha, Jeanette Marie; Harding, Fiona A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides means to identify functional CD8+ T-cell epitopes in any protein of interest. The present invention further provides CD8+ T-cell epitopes of various proteins. In additional embodiments the , present invention provides epitopes suitable for use in prophylactic and/or therapeutic vaccines. In particularly preferred embodiments the present , invention provides modified epitopes suitable for use in prophylactic and/or therapeutic vaccines. In some preferred embodiments the present invention , provides means for the development of HPV vaccines in particular multivalent , vaccines for the prevention of infection with high-risk HPV strains. In particular, the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 23, 2004 and granted January 22, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 23, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 23, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.